China Universal Asset Management Company’s Silence Therapeutics SLN Stock Holding History

China Universal Asset Management Company’s Portfolio SLN Stock Details SLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$82.1K	Sell	7,475 -860	-10%	-$6.05K	﹤0.01%	431
2026 Q1	$43.9K	Sell	8,335 -5,318	-39%	-$29.3K	﹤0.01%	464
2025 Q4	$83K	Buy	13,653 +5,421	+66%	+$34.7K	0.01%	419
2025 Q3	$42.7K	Sell	8,232 -1,214	-13%	-$6.74K	﹤0.01%	442
2025 Q2	$54.8K	Buy	9,446 +14	+0.1%	+$60	0.01%	412
2025 Q1	$26.6K	Sell	9,432 -531	-5%	-$2.59K	﹤0.01%	449
2024 Q4	$68.5K	Buy	+9,963	New	+$129K	0.01%	429

Other funds holding SLN

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

China Universal Asset Management Company's SLN Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Silence Therapeutics (SLN) stake by 10% in Q2 2026, selling an estimated $6.05K and leaving 7,475 shares worth $82.1K. The position accounts for ﹤0.01% of the portfolio, ranked #431.

China Universal Asset Management Company first reported a position in SLN in Q4 2024 and has held it in 7 quarters since. The position peaked at $83K in Q4 2025. 72 funds tracked by Wall St. Rank hold SLN as of Q2 2026.

China Universal Asset Management Company held 7,475 shares of Silence Therapeutics worth $82.1K as of Q2 2026.
China Universal Asset Management Company sold 860 Silence Therapeutics shares in Q2 2026, an estimated $6.05K.
Silence Therapeutics made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #431 holding.
China Universal Asset Management Company first reported a position in Silence Therapeutics in Q4 2024 and has held it in 7 quarters since.
China Universal Asset Management Company's Silence Therapeutics position peaked at $83K in Q4 2025.
72 funds tracked by Wall St. Rank held Silence Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.